The Eisai Co., which now owns the anti-nausea drug Aloxi, has won federal approval for an additional Aloxi use and is pursuing approval for more, citing that as justification for a six-month extension of the Aloxi patent beyond April 2015.
about the writer
Trust is at the core of a long-term financial planning relationship.
